Top 4 Small-Cap Stocks In The Biotechnology Industry With The Highest Profit Margin

Below are the top small-cap biotechnology stocks on the NYSE and the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Enzon Pharmaceuticals Inc ENZN is 92.30 percent. Enzon Pharmaceuticals' EPS for the same period is $0.65. The trailing-twelve-month profit margin at Enanta Pharmaceuticals Inc ENTA is 65.90 percent. Enanta Pharmaceuticals' revenue for the same period is $124.20 million. The trailing-twelve-month profit margin at NewLink Genetics Corp NLNK is 59.60 percent. NewLink Genetics' ROE for the same period is 96.50 percent. The trailing-twelve-month profit margin at Xenon Pharmaceuticals Inc XENE is 59.20 percent. Xenon Pharmaceuticals' PEG ratio is 1.72.